B

Biocytogen Pharmaceuticals Beijing Co Ltd
HKEX:2315

Watchlist Manager
Biocytogen Pharmaceuticals Beijing Co Ltd
HKEX:2315
Watchlist
Price: 15 HKD -1.7% Market Closed
Market Cap: 6B HKD

Biocytogen Pharmaceuticals Beijing Co Ltd
Investor Relations

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. manufactures biological products and provides related biological services. The company is headquartered in Beijing, Beijing. The company went IPO on 2022-09-01. The firm operates two business segments. The Drug Development Business segment is mainly engaged in the research and development of oncology and autoimmune disease treatments, as well as antibody development. The Preclinical Research Service segment is mainly engaged in gene editing, preclinical pharmacological efficacy evaluation and model animal sales.

Show more
Loading
2315
Hang Seng (Hong Kong)

Earnings Calls

No Earnings Calls Available

Management

Dr. Yuelei Shen Ph.D.
Chairman of the Board, CEO & GM
No Bio Available
Dr. Jian Ni
Executive Director
No Bio Available
Dr. Haichao Zhang
Senior Operation Director of Animal Center & Executive Director
No Bio Available
Mr. Bin Liu
CFO & Deputy GM
No Bio Available
Dr. Yi Yang
Chief Scientific Officer & Deputy GM
No Bio Available
Dr. Chaoshe Guo
VP of Marketing & Deputy GM
No Bio Available
Ms. Chunli Sun
Director of Human Resources & Supervisor
No Bio Available
Ms. Yan Li
Chairman of the Supervisory Committee & Director of the President's Office
No Bio Available
Dr. Qingcong Lin
Deputy GM & CEO of Biocytogen Boston Corp.
No Bio Available
Mr. Yongliang Wang
Deputy GM, Joint Company Secretary & Chief Secretariat Officer
No Bio Available

Contacts

Address
BEIJING
Beijing
12 Baoshen South Street, Daxing Bio-Medicine Industry Park, Daxing District
Contacts